NHS England consults on Cancer Drugs Fund
October 6, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, NHS England, commissioning, oncology
NHS England is declaring new changes to the way the Cancer Drugs Fund operates in order to plug a major …
West to build new manufacturing plant in Ireland
October 6, 2014Manufacturing and Production Ireland, Pharma services, US, manufacturing, west
West Pharmaceutical Services which focusses on injectable drug administration, is expanding its global manufacturing operations to include a new site …
More patients self-diagnosing online
October 6, 2014Medical Communications, Sales and Marketing Facebook, GPs, Twitter, digital, online, self-diagnosing, social media
Prior to visiting doctors more people are utilising the internet and social media to determine an illness and its subsequent …
Gamification: what’s in it for the pharma industry?
October 6, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AF, Boehringer, COPD, CRUK, Gamification, ROI, Syrum, digital
Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This …
Astellas hires Americas president
October 6, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, brian mclellan
Astellas has appointed Brian McLellan as the president of Astellas Pharma Technologies in the Americas region. McLellan is to be …
Norwich Research Park gets £12.5m investment
October 3, 2014Medical Communications, Research and Development, Sales and Marketing BBSRC, The Genome Analysis Centre (TGAC), The Sainsbury Laboratory, jic, norwich research park, the Institute of Food Research and the University of East Anglia (UEA). Plant Bioscience Limited, the Norfolk and Norwich University Hospital and The SAW Trust
The government has injected £12.5 million into the research institutions of Norwich Research Park to fund its doctoral training programme. …
Roche falls foul of NICE rules, again
October 3, 2014Medical Communications, Sales and Marketing CLL, Gazyvaro, NICE, Roche, blood cancer, oncology
Uncertainties in the data and high cost have seen NICE make an initial rejection of Roche’s new blood cancer drug …
Mixed response to EMA data transparency plans
October 3, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, BMJ, Ben Goldacre, EMA, alltrials, transparency
The European Medicines Agency has passed new rules that will mandate pharma to release more of its clinical trial data …
Kymab makes appointments and executive promotions
October 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lisha Patel, Timothy Wells, jenny yip, kymab
Following a $40 million investment from The Wellcome Trust and the Bill & Melinda Gates Foundation, biopharma UK firm Kymab …
M3 Europe appoints new business director
October 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Paul Townley-Jones, m3 europe
Healthcare tech services firm M3 Europe has appointed a business director for its European division in Paul Townley-Jones.
Bexsero and Sirturo clear winners at UK Prix Galien Awards
October 2, 2014Medical Communications, Research and Development, Sales and Marketing 2014, Bexsero, Janssen, Novartis, awards, prix galien, sirturo
The first TB medication to be approved in four decades and the first ever vaccine to treat invasive meningococcal disease …
Conservative government would ‘protect’ NHS
October 2, 2014Medical Communications, Sales and Marketing Conservatives, Labour, Miliband, NHS, burnham, david cameron, lib dems
A majority Conservative government would protect the English NHS budget in real terms from 2015 to 2020, the British prime …
Biogen Idec hires senior vice president
October 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, gene, olivier danos
US-based biotech firm Biogen Idec has hired Dr Olivier Danos to be the senior vice president of its gene therapy …
Microsoft unveils new operating system
October 1, 2014Medical Communications, Sales and Marketing EFPIA, Microsoft, Operating Systems, Solidsoft, start, windows 10
Microsoft has announced its next operating system is now due for release next year and is to host a variety …
Charities must be clear about pharma funding
October 1, 2014Medical Communications, Sales and Marketing ABPI, NICE, Sativex, charity, funding, mind, pharma
There is growing need for transparency around patient groups and health charities as they are widely perceived to be independent …
J&J bets $1.75 billion on virology
October 1, 2014Research and Development, Sales and Marketing AL-8176, Alios BioPharma, J&J, JJ, Janssen, sovaldi, viral
Johnson & Johnson has signed a deal to acquire Alios BioPharma, a privately-held company focussed on developing therapies for viral …
Chemia appoints network manager
October 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, Duncanson-Hunter, Pan, Red Door, chemia
Creston Health-owned network of agencies offering Chemia has hired a manager to run its operations. Ellie Duncanson-Hunter has been appointed …
SHL to introduce product Case Studies at the 2014 PDA Conference
October 1, 2014Sales and Marketing auto injectors, case studies, pen injectors, shl group
Taking an advanced injection device from concept to reality requires careful planning, key design and manufacturing competencies and a thorough …
Boehringer spends €100 million on inhaler
September 30, 2014Manufacturing and Production, Sales and Marketing Boehringer, Germany, Spiriva, Striverdi, inhaler, olodaterol, respimat
Boehringer Ingelheim is to spend more than €100 million at its Dortmund site in Germany in order to expand the …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
